Arbeitspapier
Pharmaceuticals: Beating the Hell Out of the Average
A lot has been written on the imminent decline of pharmaceuticals: their falling production, reduced R&D, declining innovation, the opioid crisis, patent cliffs, biting competition from generic drugs, growing opposition to IPR. The list goes on. Judging by the yardsticks that matter the most, though – namely, the companies’ relative profit and relative capitalization – pharmaceuticals are doing just fine. In fact, based on these yardsticks, they remain the most powerful corporate sector of all.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Note
- Classification
-
Wirtschaft
Capitalist Systems: Political Economy
Socialist Systems and Transitional Economies: Political Economy; Property Rights
- Subject
-
capitalization
finance
pharmaceutical
power
profit
- Event
-
Geistige Schöpfung
- (who)
-
Nitzan, Jonathan
Bichler, Shimshon
- Event
-
Veröffentlichung
- (who)
-
The Bichler and Nitzan Archives
- (where)
-
Toronto
- (when)
-
2021
- Handle
- Last update
-
10.03.2025, 11:44 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Arbeitspapier
Associated
- Nitzan, Jonathan
- Bichler, Shimshon
- The Bichler and Nitzan Archives
Time of origin
- 2021
Other Objects (12)
The Scientist and the Church
No Way Out: Crime, Punishment and the Limits to Power (Transcript and Video)
Francis’ Buy-to-Build Estimates for Britain and the United States: A Comment
Can Capitalists Afford a Trumped Recovery?
The Capital as Power Aproach: An Invited-then-Rejected Interview with Shimshon Bichler and Jonathan Nitzan
The Business of Strategic Sabotage
The Mismatch Thesis. Fiction and Reality in the Accumulation of Capital
Capital Accumulation: Breaking the Dualism of "Economics" and "Politics"
The 1-2-3 Toolbox of Mainstream Economics: Promising Everything, Delivering Nothing
Can Capitalists Afford Recovery? A 2018 Update
Imperialism and Financialism. A Story of a Nexus
Still About Oil?
The Scientist and the Church
No Way Out: Crime, Punishment and the Limits to Power (Transcript and Video)
Francis’ Buy-to-Build Estimates for Britain and the United States: A Comment
Can Capitalists Afford a Trumped Recovery?
The Capital as Power Aproach: An Invited-then-Rejected Interview with Shimshon Bichler and Jonathan Nitzan
The Business of Strategic Sabotage
The Mismatch Thesis. Fiction and Reality in the Accumulation of Capital
Capital Accumulation: Breaking the Dualism of "Economics" and "Politics"
The 1-2-3 Toolbox of Mainstream Economics: Promising Everything, Delivering Nothing
Can Capitalists Afford Recovery? A 2018 Update
Imperialism and Financialism. A Story of a Nexus
Still About Oil?
The Scientist and the Church
No Way Out: Crime, Punishment and the Limits to Power (Transcript and Video)
Francis’ Buy-to-Build Estimates for Britain and the United States: A Comment
Can Capitalists Afford a Trumped Recovery?
The Capital as Power Aproach: An Invited-then-Rejected Interview with Shimshon Bichler and Jonathan Nitzan
The Business of Strategic Sabotage
The Mismatch Thesis. Fiction and Reality in the Accumulation of Capital
Capital Accumulation: Breaking the Dualism of "Economics" and "Politics"
The 1-2-3 Toolbox of Mainstream Economics: Promising Everything, Delivering Nothing
Can Capitalists Afford Recovery? A 2018 Update
Imperialism and Financialism. A Story of a Nexus